Shopping Cart
- Remove All
- Your shopping cart is currently empty
GDC-2394, an orally active, selective NLRP3 inhibitor, also targets IL-1β, exhibiting inhibitory concentrations (IC50s) of 0.4 μM (human IL-1β) and 0.1 μM (mouse IL-1β). It effectively hampers NLRP3-induced caspase-1 activity while not affecting NLRC4-dependent inflammasome activation.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,250 | 8-10 weeks | |
50 mg | $1,630 | 8-10 weeks | |
100 mg | $2,480 | 8-10 weeks |
Description | GDC-2394, an orally active, selective NLRP3 inhibitor, also targets IL-1β, exhibiting inhibitory concentrations (IC50s) of 0.4 μM (human IL-1β) and 0.1 μM (mouse IL-1β). It effectively hampers NLRP3-induced caspase-1 activity while not affecting NLRC4-dependent inflammasome activation. |
Molecular Weight | 431.51 |
Formula | C20H25N5O4S |
Cas No. | 2238822-07-4 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.